|
ANTIBIOTIC REGIMEN AND TIMING OF PROPHYLAXIS ARE IMPORTANT FACTORS FOR LIMITING SURGICAL SITE INFECTION (SSI) IN ELECTIVE ABDOMINAL COLORECTAL SURGERY (ECRS)
Vanessa P Ho, MD, Philip S Barie, MD, MBA, Sharon L Stein, MD, Koiana Trencheva, MS, Jeffrey W Milsom, MD, Sang W Lee, MD, Toyooki Sonoda, MD, Weill Cornell Medical College
Background: Surgical site infections (SSI) cause morbidity after eCRS, and antibiotic prophylaxis can decrease SSI. This study hypothesized that antibiotic administration factors (AAF) reduce the risk of SSI. Methods: Retrospective review from a prospective database of a random sample of patients with eCRS with anastomosis. Antibiotic regimens, initial dose timing (IDT), and redosing were evaluated. Appropriate regimens (APC) covered gram-positive cocci, gram-negative bacilli, and anaerobes. IDT was proper if given < 30 min prior to incision; redosing parameters were determined pharmacokinetically for each agent. The main outcome was SSI (CDC definitions). Sequential logistic models were generated: Model 1 assessed AAF, Model 2 controlled for patient and clinical factors^; a= 0.05*. Results: 605 patients (292 male (48.3%), mean age 59.7 (SD 17.8) years) were included; diagnoses included cancer (235, 38.8%), IBD (133, 22.0%) and diverticulitis (107, 17.7%). 76 patients (12.6%) had incisional SSI and 54 (8.9%) had organ/space SSI. Regimens included cefazolin (CZL) + metronidazole (MET) in 219 (36.2%), cefoxitin (FOX) in 214 (35.4%), and levofloxacin (LFX) + MET in 48 (7.9%); 124 (20.5%) utilized other regimens (OTH). 55 (9.1%) received insufficient coverage, 356 (58.8%) had proper IDT, and 401 (66.3%) regimens were redosed properly. In Model 1, OTH regimens increased SSI risk, and proper IDT was protective (Table). After adding clinical factors (Model 2^), IDT remained protective; but increased OTH risk approached significance. Conclusions: Appropriate antibiotic selection and timing of administration for prophylaxis are most crucial to limit SSI in eCRS. | Model | Parameters | OR | 95% CI | | 1 | CZL-MET | 1.00 | Reference | | | FOX | 1.17 | 0.724 - 1.899 | | | LFX-MET | 0.72 | 0.297 - 1.723 | | | OTH | 1.963* | 1.028 - 3.749 | | | APC | 1.00 | Reference | | | Under-Coverage | 0.58 | 0.246 - 1.365 | | | Over-Coverage | 0.74 | 0.261 - 2.068 | | | IDT | 0.592* | 0.397 - 0.882 | | | Redosing | 0.89 | 0.581 - 1.363 | | 2^ | CZL-MET | 1.00 | Reference | | | FOX | 1.04 | 0.567 - 1.903 | | | LFX-MET | 0.59 | 0.204 - 1.684 | | | OTH | 2.27 | 0.984 - 5.251 | | | APC | 1.00 | Reference | | | Under-Coverage | 0.34 | 0.113 - 1.041 | | | Over-Coverage | 0.37 | 0.099 - 1.397 | | | IDT | 0.538* | 0.324 - 0.894 | | | Redosing | 0.81 | 0.469 - 1.412 |
^ disease, surgeon experience, transfusion, wound class, type of surgery, history of radiation, [albumin], comorbidities, intraoperative factors [Temp, PO2], glycemic control, ICU admission
Back to Program
|